Repurposing UDCA, an FXR Inhibitor, to Prevent SARS-Cov-2 Infection

Gastroenterology. 2023 May;164(6):1019-1020. doi: 10.1053/j.gastro.2023.01.014. Epub 2023 Jan 19.

Authors

Khairunnadiya Prayitno¹, Mamatha Bhat²

Affiliations

¹ Multi-Organ Transplant Program, Ajmera Transplant Centre, University Health Network, Toronto, Ontario, Canada.
² Multi-Organ Transplant Program, Ajmera Transplant Centre, University Health Network, Toronto, Ontario, Canada; Division of Gastroenterology & Hepatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

No abstract available

Publication types

Comment

MeSH terms

Antiviral Agents / therapeutic use
COVID-19*
Drug Repositioning
Humans
Molecular Docking Simulation
SARS-CoV-2
Transcription Factors
Ursodeoxycholic Acid

Substances

Transcription Factors
Ursodeoxycholic Acid
Antiviral Agents